Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Mutation analysis of the EGFR pathway genes, EGFR, RAS, PIK3CA, BRAF, and AKT1, in salivary gland adenoid cystic carcinoma.

Saida K, Murase T, Ito M, Fujii K, Takino H, Masaki A, Kawakita D, Ijichi K, Tada Y, Kusafuka K, Iida Y, Onitsuka T, Yatabe Y, Hanai N, Hasegawa Y, Shinomiya H, Nibu KI, Shimozato K, Inagaki H.

Oncotarget. 2018 Mar 30;9(24):17043-17055. doi: 10.18632/oncotarget.24818. eCollection 2018 Mar 30.

2.

Reoperation following the use of non-standardized procedures for malignant parotid tumors.

Zhang X, Zeng X, Lan X, Huang J, Luo K, Tian K, Wu X, Xiao F, Li S.

Oncol Lett. 2017 Dec;14(6):6701-6707. doi: 10.3892/ol.2017.7020. Epub 2017 Sep 21.

3.

MYB Translocation Status in Salivary Gland Epithelial-Myoepithelial Carcinoma: Evaluation of Classic, Variant, and Hybrid Forms.

Bishop JA, Westra WH.

Am J Surg Pathol. 2018 Mar;42(3):319-325. doi: 10.1097/PAS.0000000000000990.

PMID:
29135517
4.

Aggressive Adenoid Cystic Carcinoma of Maxillary Sinus in a 43-Year-Old Male: Rare Case Report and Review of Literature.

Rahmani K, Taghipour Zahir S, Baghi Yazdi M, Navabazam A.

Case Rep Med. 2017;2017:2324717. doi: 10.1155/2017/2324717. Epub 2017 Sep 28.

5.

Clinical and molecular insights into adenoid cystic carcinoma: Neural crest-like stemness as a target.

Yarbrough WG, Panaccione A, Chang MT, Ivanov SV.

Laryngoscope Investig Otolaryngol. 2016 Aug 4;1(4):60-77. doi: 10.1002/lio2.22. eCollection 2016 Aug. Review.

6.

A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma.

Goncalves PH, Heilbrun LK, Barrett MT, Kummar S, Hansen AR, Siu LL, Piekarz RL, Sukari AW, Chao J, Pilat MJ, Smith DW, Casetta L, Boerner SA, Chen A, Lenkiewicz E, Malasi S, LoRusso PM.

Oncotarget. 2017 May 16;8(20):32918-32929. doi: 10.18632/oncotarget.16464.

7.

AGR2 promotes the proliferation, migration and regulates epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.

Ma SR, Mao L, Deng WW, Li YC, Bu LL, Yu GT, Zhang WF, Sun ZJ.

Am J Transl Res. 2017 Feb 15;9(2):507-519. eCollection 2017.

8.

Long-term local control rates of patients with adenoid cystic carcinoma of the head and neck managed by surgery and postoperative radiation.

Ali S, Palmer FL, Katabi N, Lee N, Shah JP, Patel SG, Ganly I.

Laryngoscope. 2017 Oct;127(10):2265-2269. doi: 10.1002/lary.26565. Epub 2017 Mar 21.

9.

Defining the surgical margins of adenoid cystic carcinoma and their impact on outcome: An international collaborative study.

Amit M, Na'ara S, Trejo-Leider L, Ramer N, Burstein D, Yue M, Miles B, Yang X, Lei D, Bjoerndal K, Godballe C, Mücke T, Wolff KD, Eckardt AM, Copelli C, Sesenna E, Patel S, Ganly I, Gil Z.

Head Neck. 2017 May;39(5):1008-1014. doi: 10.1002/hed.24740. Epub 2017 Mar 2.

10.

Risk factors and prognosis for salivary gland adenoid cystic carcinoma in southern china: A 25-year retrospective study.

Ouyang DQ, Liang LZ, Zheng GS, Ke ZF, Weng DS, Yang WF, Su YX, Liao GQ.

Medicine (Baltimore). 2017 Feb;96(5):e5964. doi: 10.1097/MD.0000000000005964.

11.

Primary adenoid cystic carcinoma of the trachea with thyroid invasion: a case report and literature review.

Qi D, Feng L, Li J, Liu B, Zhang Q.

Onco Targets Ther. 2016 Oct 13;9:6291-6296. eCollection 2016.

12.

Clinical significance of post-surgical residual tumor burden and radiation therapy in treating patients with lacrimal adenoid cystic carcinoma.

Noh JM, Lee E, Ahn YC, Oh D, Kim YD, Woo KI, Ko YH, Kim S.

Oncotarget. 2016 Sep 13;7(37):60639-60646. doi: 10.18632/oncotarget.10259.

13.

Adenoid cystic carcinoma of head and neck: clinical predictors of outcome from a Canadian centre.

Ko JJ, Siever JE, Hao D, Simpson R, Lau HY.

Curr Oncol. 2016 Feb;23(1):26-33. doi: 10.3747/co.23.2898. Epub 2016 Feb 18.

14.

An Unusual Presentation of Adenoid Cystic Carcinoma.

Gill KS, Frattali MA.

Case Rep Otolaryngol. 2015;2015:826436. doi: 10.1155/2015/826436. Epub 2015 Dec 24.

15.
16.

Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study.

Ganly I, Amit M, Kou L, Palmer FL, Migliacci J, Katabi N, Yu C, Kattan MW, Binenbaum Y, Sharma K, Naomi R, Abib A, Miles B, Yang X, Lei D, Bjoerndal K, Godballe C, Mücke T, Wolff KD, Fliss D, Eckardt AM, Chiara C, Sesenna E, Ali S, Czerwonka L, Goldstein DP, Gil Z, Patel SG.

Eur J Cancer. 2015 Dec;51(18):2768-76. doi: 10.1016/j.ejca.2015.09.004. Epub 2015 Nov 19.

17.

Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling.

Chae YK, Chung SY, Davis AA, Carneiro BA, Chandra S, Kaplan J, Kalyan A, Giles FJ.

Oncotarget. 2015 Nov 10;6(35):37117-34. doi: 10.18632/oncotarget.5076. Review.

18.

Role of hypoxia-inducible factor-1α and CD146 in epidermal growth factor receptor-mediated angiogenesis in salivary gland adenoid cystic carcinoma.

Wang WM, Zhao ZL, Zhang WF, Zhao YF, Zhang L, Sun ZJ.

Mol Med Rep. 2015 Sep;12(3):3432-3438. doi: 10.3892/mmr.2015.3815. Epub 2015 May 22.

19.

Clinicopathological review and survival characteristics of adenoid cystic carcinoma.

Binesh F, Akhavan A, Masumi O, Mirvakili A, Behniafard N.

Indian J Otolaryngol Head Neck Surg. 2015 Mar;67(Suppl 1):62-6. doi: 10.1007/s12070-014-0755-x. Epub 2014 Aug 5.

20.

Inhibition of mTOR reduce Stat3 and PAI related angiogenesis in salivary gland adenoid cystic carcinoma.

Yu GT, Bu LL, Zhao YY, Liu B, Zhang WF, Zhao YF, Zhang L, Sun ZJ.

Am J Cancer Res. 2014 Nov 19;4(6):764-75. eCollection 2014.

Supplemental Content

Support Center